Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction

Erwin, 2019, Congenital erythropoietic porphyria: recent advances, Mol Genet Metab, 128, 288, 10.1016/j.ymgme.2018.12.008 Kauffman, 1991, Bone-marrow transplantation for congenital erythropoietic porphyria, Lancet, 337, 1510, 10.1016/0140-6736(91)93198-I Thomas, 1996, Correction of congenital erythropoietic porphyria by bone marrow transplantation, J Pediatr, 129, 453, 10.1016/S0022-3476(96)70082-3 Zix-Kieffer, 1996, Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease), Bone Marrow Transplant, 18, 217 Lagarde, 1998, [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease], Ann Dermatol Venereol, 125, 114 Tezcan, 1998, Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation, Blood, 92, 4053, 10.1182/blood.V92.11.4053 Fritsch, 1998, Congenital erythropoietic porphyria, Skin Pharmacol Appl Skin Physiol, 11, 347, 10.1159/000029857 Shaw, 2001, Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature, Bone Marrow Transplant, 27, 101, 10.1038/sj.bmt.1702738 Harada, 2001, Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation, J Am Acad Dermatol, 45, 279, 10.1067/mjd.2001.114730 Dupuis-Girod, 2005, Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease), Eur J Pediatr, 164, 104, 10.1007/s00431-004-1575-x Phillips, 2007, Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria, Blood, 109, 2618, 10.1182/blood-2006-06-022848 Taibjee, 2007, Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: a treatment dilemma, Br J Dermatol, 156, 567, 10.1111/j.1365-2133.2006.07699.x Faraci, 2008, Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria, Pediatr Transplant, 12, 117, 10.1111/j.1399-3046.2007.00842.x Lebreuilly-Sohyer, 2010, Congenital erythropoietic porphyria treated by haematopoietic stem cell allograft], Ann Dermatol Venereol, 137, 635, 10.1016/j.annder.2010.06.018 Singh, 2012, Bone marrow transplantation improves symptoms of congenital erythropoietic porphyria even when done post puberty, Indian J Dermatol Venereol Leprol, 78, 108, 10.4103/0378-6323.90963 Martinez Peinado, 2013, Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation, Pediatr Dermatol, 30, 484, 10.1111/pde.12117 Karakurt, 2015, Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1, Pediatr Transplant, 19, 803, 10.1111/petr.12571 Elder, 1990, Laboratory investigation of the porphyrias, Ann Clin Biochem, 27, 395, 10.1177/000456329002700501 Deybach, 1980, Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk, Hum Genet, 53, 217, 10.1007/BF00273499 1994, Interobserver and intraobserver variations in liver biopsy interpretation in patients with chronic hepatitis C, Hepatology, 20, 15 Katugampola, 2012, A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases, Br J Dermatol, 167, 888, 10.1111/j.1365-2133.2012.11154.x Egan, 2015, Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria, Blood, 126, 257, 10.1182/blood-2014-07-584664 Wisell, 2006, Glycogen pseudoground glass change in hepatocytes, Am J Surg Pathol, 30, 1085, 10.1097/01.pas.0000208896.92988.fc Lefkowitch, 2006, Ground-glass, polyglucosan-like hepatocellular inclusions: a “new” diagnostic entity, Gastroenterology, 131, 713, 10.1053/j.gastro.2006.07.006 Yin, 2013, Hepatic stellate cells in liver development, regeneration, and cancer, J Clin Invest, 123, 1902, 10.1172/JCI66369 Hagiwara, 2015, Impaired expression of ATP-binding cassette transporter G2 and liver damage in erythropoietic protoporphyria, Hepatology, 62, 1638, 10.1002/hep.27871 González-Estrada, 2014, Sporadic porphyria cutanea tarda: treatment with chloroquine decreases hyperglycemia and reduces development of metabolic syndrome, Eur J Intern Med, 25, e76, 10.1016/j.ejim.2014.02.009